Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The primary purpose of this study is to asess the safety and tolerability of ascending single oral doses of PRA-027 in healthy women of nonchildbearing potential. The secondary purpose is to provide the initial pharmacokinetic (PK) and pharmacodynamic (PD) profile of PRA-027 in healthy women of nonchildbearing potential, and to evaluate the effect of a high-fat meal on the PK and PD of PRA-027 administered to healthy women of nonchildbearing potential.
Epistemonikos ID: 47a787857db503b9a918f19f9ace46ed44a8903e
First added on: May 04, 2024